Cite
HARVARD Citation
Dikranian, A. et al. (n.d.). AB0454 FREQUENCY AND DURATION OF EARLY NON-SERIOUS ADVERSE EVENTS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOFACITINIB 5 MG TWICE DAILY AS MONOTHERAPY AND COMBINATION THERAPY. Annals of the rheumatic diseases. pp. 1690-1691. [Online].